10045-MET-4 CEREBROSPINAL FLUID DIVERSION FOLLOWED BY SYSTEMIC THERAPY FOR LEPTOMENINGEAL METASTASIS-RELATED HYDROCEPHALUS IN PATIENTS WITH SOLID CANCER: ASSESSMENT WITH CLASSIFICATION OF EANO-ESMO CLINICAL PRACTICE GUIDELINE

Koichi Mitsuya, Shoichi Deguchi, Takahiro Suzuki, Nakamasa Hayashi · 2023

Read 10045-MET-4 CEREBROSPINAL FLUID DIVERSION FOLLOWED BY SYSTEMIC THERAPY FOR LEPTOMENINGEAL METASTASIS-RELATED HYDROCEPHALUS IN PATIENTS WITH SOLID CANCER: ASSESSMENT WITH CLASSIFICATION OF EANO-ESMO CLINICAL PRACTICE GUIDELINE by Koichi Mitsuya, Shoichi Deguchi, Takahiro Suzuki, Nakamasa Hayashi (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10710570.txt.

Description

Koichi Mitsuya, Shoichi Deguchi, Takahiro Suzuki, and Nakamasa Hayashi review fluid diversion plus drug care for cancer spread to the brain lining in two thousand twenty-three. That spread can block spinal fluid flow and raise pressure in the skull, a hard state to control. The team studied patients with solid cancers treated over fifteen years.

Eighty patients needed a fluid shunt for the block. Shunt plus chemo or radiation was offered when other spread was controlled and life expectancy passed three months. Nine in ten patients improved fast in daily function after the shunt. Those who kept on maintenance chemo lived clearly longer than those who did not. Cases were also classed by a European guideline frame.

Catalog record

CREATORKoichi Mitsuya, Shoichi Deguchi, Takahiro Suzuki, Nakamasa Hayashi
YEAR2023
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC10710570

Browse the full library · About the Tower of Babel